$Factors affecting refractoriness or recurrence in diffuse large B-cell lymphoma: development and validation of a novel predictive nomogram$

Factors affecting refractoriness or recurrence in diffuse large B-cell lymphoma: development and validation of a novel predictive nomogram

Background Relapsed/Refractory (R/R) diffuse large B-cell lymphoma (DLBCL) represents a subgroup with a high incidence and dismal prognosis. Currently, there is a lack of robust models for predicting R/R DLBCL. Therefore, we conducted a retrospective study to identify key determinants to be incorpor...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yiwei Guo, Jie Lian, Yao Chen, Lina Quan, Xiuchen Guo, Jingbo Zhang, Zhiqiang Liu, Aichun Liu
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2025-12-01
Series:	Hematology
Subjects:	Diffuse large B-cell lymphoma refractoriness recurrence clinical indicator nomogram
Online Access:	https://www.tandfonline.com/doi/10.1080/16078454.2024.2445395
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Recurrent Diffuse Large B-Cell Lymphoma with the Initial Manifestation of Retinal Involvement
by: Wan-Ting Yeh, et al.
Published: (2023-07-01)

Real life clinical outcomes of relapsed/refractory diffuse large B cell lymphoma in the rituximab era: The STRIDER study
by: Irene Dogliotti, et al.
Published: (2024-07-01)

Outcome of autologous bone marrow transplant in patients with relapsed and refractory diffuse large B-cell lymphoma in relation with prognostic factor: A single-center experience
by: Fawaz Salim Yousif, et al.
Published: (2024-12-01)

Chidamide plus R‐GDP for relapsed/refractory diffuse large B‐cell lymphoma in patients ineligible for autologous transplantation: A prospective, single‐arm, phase II study
by: Guang‐Liang Chen, et al.
Published: (2024-08-01)

Treatment of refractory cervical burkitt lymphoma: A case report
by: Lan Gao, et al.
Published: (2025-01-01)

Prognostic factors and predictive models for primary pulmonary diffuse large B-cell lymphoma: a population-based analysis
by: Xiaoyu He, et al.
Published: (2024-12-01)

Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients
by: Gianmarco Bagnato, et al.
Published: (2024-01-01)

Nomogram for predicting early recurrence of hepatocellular carcinoma with narrow resection margin
by: Jinyu Zhang, et al.
Published: (2024-11-01)

Comparative Analysis of the Clinical Manifestations of Sinonasal Natural Killer T-Cell Lymphoma and Diffuse Large B-Cell Lymphoma
by: Chol Ho Shin, et al.
Published: (2024-07-01)

On the return process with refractoriness for a non-homogeneous Ornstein-Uhlenbeck neuronal model
by: Virginia Giorno, et al.
Published: (2013-09-01)

Predictive nomograms of repeat intrahepatic recurrence and overall survival after radiofrequency ablation of recurrent colorectal liver metastases
by: Ji-Chen Wang, et al.
Published: (2024-12-01)

Nomograms for predicting recurrence of HER2‐positive breast cancer with different HR status based on ultrasound and clinicopathological characteristics
by: Xudong Zhang, et al.
Published: (2024-09-01)

A Nomogram for Predicting Recurrence in Stage I Non‐Small Cell Lung Cancer
by: Rongrong Bian, et al.
Published: (2024-11-01)

Prolonged remission with ibrutinib maintenance therapy following radiation in a patient with relapsed primary CNS lymphoma
by: Steven Du, et al.
Published: (2024-12-01)

INNOVATIVE MANAGEMENT OF REFRACTORY CLASSICAL HODGKIN LYMPHOMA WITH ATYPICAL HEPATIC PRESENTATION: A CASE STUDY
by: Candaş Mumcu, et al.
Published: (2024-12-01)

A Nomogram Model for Predicting Recurrent Coronary Thrombosis in Kawasaki Disease Patients
by: Zhou X, et al.
Published: (2025-01-01)

Development and verification of a nomogram for recurrence risk of Benign Paroxysmal Positional Vertigo in middle-aged and older populations
by: Bo Tang, et al.
Published: (2024-12-01)

Cutaneous manifestations as the presenting signs of diffuse large B-cell lymphoma/high-grade B-cell lymphoma with MYC and BCL2 rearrangements
by: Gabriela Piñero-Crespo, BS, et al.
Published: (2025-01-01)

Development and validation of a nomogram to predict recurrence in epithelial ovarian cancer using complete blood count and lipid profiles
by: Xi Tang, et al.
Published: (2025-02-01)

DL-ICE as a bridge to allogeneic transplantation in relapsed/refractory PTCL: survival outcomes and prognostic factors
by: Tong-Yoon Kim, et al.
Published: (2024-12-01)

Primary pulmonary diffuse large B cell lymphoma presenting with features of organizing pneumonia: a case report
by: Sunjie Li, et al.
Published: (2025-01-01)

Primary giant ovarian diffuse large B-cell lymphoma
by: Maoyu Zhang, et al.
Published: (2025-02-01)

Nomogram for predicting post-progression-free survival in patients with recurrent pancreatic ductal adenocarcinoma after radical surgery: a retrospective analysis
by: Dailei Qin, et al.
Published: (2024-12-01)

Impact of circulating lymphoma cells at diagnosis on outcomes in patients with newly diagnosed de novo diffuse large B-cell lymphoma
by: Sayan Mullick Chowdhury, et al.
Published: (2025-01-01)

Very late relapse of Burkitt's lymphoma in an EBV-negative patient after 20 years of complete remission
by: Kmar Mrad, et al.
Published: (2024-01-01)

MANAGEMENT OF CHEMOTHERAPY-RESISTANT GASTRIC DIFFUSE LARGE B-CELL LYMPHOMA: A CASE REPORT
by: Hüseyin Derya Dinçyürek, et al.
Published: (2024-12-01)

REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
by: Emmanuel Gyan, et al.
Published: (2015-02-01)

Primary diffuse large B-cell lymphoma of the prostate: Histopathological diagnosis of a rare entity in the prostate
by: Richa Sharma, et al.
Published: (2024-12-01)

Nomogram Based on Immune-Inflammatory Score and Classical Clinicopathological Parameters for Predicting the Recurrence of Endometrial Carcinoma: A Large, Multi-Center Retrospective Study
by: Wang Y, et al.
Published: (2024-12-01)

Characterization of the genomic landscape of canine diffuse large B-cell lymphoma reveals recurrent H3K27M mutations linked to progression-free survival
by: Anna Darlene van der Heiden, et al.
Published: (2025-02-01)

Periprostatic fat magnetic resonance imaging based radiomics nomogram for predicting biochemical recurrence-free survival in patients with non-metastatic prostate cancer after radical prostatectomy
by: Xiao-Hui Wu, et al.
Published: (2024-11-01)

Prognostic Nutritional Index Predicts Early Mortality in Diffuse Large B-cell Lymphoma
by: Erman OZTURK, et al.
Published: (2022-03-01)

Revealing the heterogeneity of treatment resistance in less‐defined subtype diffuse large B cell lymphoma patients by integrating programmed cell death patterns and liquid biopsy
by: Wei Hua, et al.
Published: (2025-01-01)

A rare case of CD20− primary cutaneous diffuse large B-cell lymphoma, leg type
by: Juliette M. Kersten, MD, et al.
Published: (2024-12-01)

HBx integration in diffuse large B-cell lymphoma inhibits Caspase-3-PARP related apoptosis
by: Yanchun Wang, et al.
Published: (2024-12-01)

CLINICAL CHARACTERISTICS AND PROGNOSTIC FACTORS IN PRIMARY BREAST DIFFUSE LARGE B-CELL LYMPHOMA
by: guangliang Chen, et al.
Published: (2022-08-01)

The role of the gut microbiota in infectious complications during immunochemotherapy for diffuse large B-cell lymphoma
by: Man Sun, et al.
Published: (2024-12-01)

Subcutaneous rituximab in patients with diffuse large B cell lymphoma and follicular lymphoma: Final results of the non‐interventional study MabSCale
by: Jan Dürig, et al.
Published: (2023-02-01)

Case Report: Diffuse cerebral lymphomatosis with superimposed multifocal primary CNS lymphoma
by: Elizabeth Huai-Feng Li, et al.
Published: (2024-11-01)

Chromosomal Abnormalities as a Predisposition to Secondary Neurolymphomatosis in Patients with Diffuse Large B-Cell Lymphoma: A Report of Two Cases and a Literature Review
by: Naoki Watanabe, et al.
Published: (2024-10-01)